{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:51Z","timestamp":1792784991517,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"American Cancer Society Research","award":["TBE-111831"],"award-info":[{"award-number":["TBE-111831"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"crossref"}]},{"name":"ACS Institutional"},{"name":"Papanicoulau Corps for Cancer Research"},{"name":"Women\u2019s Cancer Association of the University of Miami, the Wendy Will Case Cancer Fund"},{"name":"Department of Defense Breast Cancer Research Program","id":[{"id":"https:\/\/ror.org\/03xzf6x18","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Leadership Alliance Summer Research Early Identification Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbrc.2009.12.123","type":"journal-article","created":{"date-parts":[[2009,12,29]],"date-time":"2009-12-29T04:07:04Z","timestamp":1262059624000},"page":"1548-1554","source":"Crossref","is-referenced-by-count":220,"title":["Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia"],"prefix":"10.1016","volume":"391","author":[{"given":"Margaret E.","family":"Benny Klimek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tufan","family":"Aydogdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majik J.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas G.","family":"Koniaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Zimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.12.123_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","article-title":"Cachexia: prevalence and impact in medicine","volume":"11","author":"Tan","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbrc.2009.12.123_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2009.12.123_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2009.12.123_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tig.2007.08.008","article-title":"Sprinting without myostatin a genetic determinant of athletic prowess","volume":"23","author":"Lee","year":"2007","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2009.12.123_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MCO.0b013e32830007e2","article-title":"Myostatin is a procachectic growth factor during postnatal myogenesis","volume":"11","author":"McFarlane","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbrc.2009.12.123_bib6","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00018-008-8077-3","article-title":"Myostatin as a therapeutic target for musculoskeletal disease","volume":"65","author":"Bradley","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2009.12.123_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2009.12.123_bib8","doi-asserted-by":"crossref","first-page":"e1628","DOI":"10.1371\/journal.pone.0001628","article-title":"Genetic analysis of the role of proteolysis in the activation of latent myostatin","volume":"3","author":"Lee","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2009.12.123_bib9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2009.12.123_bib10","doi-asserted-by":"crossref","first-page":"40735","DOI":"10.1074\/jbc.M206379200","article-title":"The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum","volume":"277","author":"Hill","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.12.123_bib11","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.12.123_bib12","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.12.123_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.expneurol.2009.02.017","article-title":"A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis","volume":"217","author":"Morrison","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2009.12.123_bib14","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1152\/ajpregu.00138.2009","article-title":"Pre-treatment with a soluble activin type IIB receptor\/Fc fusion protein improves hypoxia-induced muscle dysfunction","volume":"298","author":"Pistilli","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbrc.2009.12.123_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ijo.2009.162","article-title":"The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity","volume":"33","author":"Akpan","year":"2009","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.bbrc.2009.12.123_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/jhep.2003.50318","article-title":"Massive liver growth in mice induced by systemic interleukin 6 administration","volume":"38","author":"Zimmers","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.12.123_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2009.12.123_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bjc.1993.174","article-title":"Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice","volume":"67","author":"Ohe","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2009.12.123_bib19","first-page":"4091","article-title":"Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI","volume":"19","author":"Kawamura","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2009.12.123_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1534-5807(04)00107-8","article-title":"Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin","volume":"6","author":"Iezzi","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2009.12.123_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm1479","article-title":"Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors","volume":"12","author":"Minetti","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2009.12.123_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/156800909789057015","article-title":"Deacetylase inhibitors modulate the myostatin\/follistatin axis without improving cachexia in tumor-bearing mice","volume":"9","author":"Bonetto","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2009.12.123_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4049\/jimmunol.167.1.399","article-title":"Cytokine-responsive gene-2\/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration","volume":"167","author":"Koniaris","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2009.12.123_bib24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.hep.2003.09.021","article-title":"Resolving the role of IL-6 in liver regeneration","volume":"38","author":"Zimmers","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.12.123_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.21087","article-title":"Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair","volume":"43","author":"Jin","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.12.123_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.21728","article-title":"Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection","volume":"46","author":"Jin","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.12.123_bib27","article-title":"Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice","author":"Jin","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2009.12.123_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2009.12.123_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2009.12.123_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","article-title":"Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis","volume":"23","author":"Holzbaur","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2009.12.123_bib31","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1172\/JCI28520","article-title":"Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition","volume":"116","author":"Ohsawa","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2009.12.123_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/en.2006-0539","article-title":"Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy","volume":"148","author":"Gilson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2009.12.123_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcp.20778","article-title":"Prolonged absence of myostatin reduces sarcopenia","volume":"209","author":"Siriett","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2009.12.123_bib34","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1152\/ajpendo.00275.2002","article-title":"Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension","volume":"285","author":"McMahon","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2009.12.123_bib35","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.0604893104","article-title":"Lack of myostatin results in excessive muscle growth but impaired force generation","volume":"104","author":"Amthor","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.12.123_bib36","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1093\/hmg\/ddp253","article-title":"Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice","volume":"18","author":"Sumner","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2009.12.123_bib37","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI116816","article-title":"Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo","volume":"92","author":"Strassmann","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2009.12.123_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Invest."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09024966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09024966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T02:56:11Z","timestamp":1544756171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X09024966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0006291X09024966"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.12.123","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}